Ajooni Biotech (India) Analysis

Ajooni Stock Analysis Notes

The company has price-to-book (P/B) ratio of 1.81. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ajooni Biotech had not issued any dividends in recent years. The entity had 5:1 split on the 7th of October 2022. For more info on Ajooni Biotech Limited please contact Gursimran Singh at 91 17 2502 0758 or go to https://www.ajoonibiotech.com.

Ajooni Biotech Investment Alerts

Ajooni Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 774.1 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ajooni Biotech's market, we take the total number of its shares issued and multiply it by Ajooni Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Ajooni Profitablity

The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.03 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.03.

Management Efficiency

Ajooni Biotech has return on total asset (ROA) of 0.0139 % which means that it generated a profit of $0.0139 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0354 %, meaning that it generated $0.0354 on every $100 dollars invested by stockholders. Ajooni Biotech's management efficiency ratios could be used to measure how well Ajooni Biotech manages its routine affairs as well as how well it operates its assets and liabilities. At present, Ajooni Biotech's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 339.4 M, whereas Non Current Assets Total are forecasted to decline to about 80.7 M.

Technical Drivers

As of the 26th of November, Ajooni Biotech shows the Risk Adjusted Performance of 0.0576, downside deviation of 2.9, and Mean Deviation of 2.68. Ajooni Biotech technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Ajooni Biotech Price Movement Analysis

Ajooni Biotech Outstanding Bonds

Ajooni Biotech Predictive Daily Indicators

Ajooni Biotech Forecast Models

Ajooni Biotech's time-series forecasting models are one of many Ajooni Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ajooni Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ajooni Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ajooni shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ajooni Biotech. By using and applying Ajooni Stock analysis, traders can create a robust methodology for identifying Ajooni entry and exit points for their positions.

When running Ajooni Biotech's price analysis, check to measure Ajooni Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ajooni Biotech is operating at the current time. Most of Ajooni Biotech's value examination focuses on studying past and present price action to predict the probability of Ajooni Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ajooni Biotech's price. Additionally, you may evaluate how the addition of Ajooni Biotech to your portfolios can decrease your overall portfolio volatility.